Cholestyramine Resin: all 22 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- PFAS Clinical TrialNot yet recruitingNCT07836023Phase 2
- Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of POPs in Obese Female PatientsRecruitingNCT05966727Not applicable
- Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel SyndromeTerminatedNCT04046328Phase 2Results posted
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCompletedNCT03510884Phase 3Results posted
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial HypercholesterolemiaCompletedNCT03510715Phase 3Results posted
- An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCompletedNCT02890992Phase 2Results posted
- Comparison of Colesevelam Hydrogen Chloride (HCl) Powder For Oral Suspension Versus Generic Cholestyramine Through Use of the Bile Acid Sequestrant Acceptability (BASA) ScaleCompletedNCT01122108Phase 4Results posted
- A Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation StudyCompletedNCT01062269Phase 4Results posted
- A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy ParticipantsCompletedNCT05894928Phase 1
- Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis PatientsCompletedNCT05577507Phase 4
- A Clinical Study to Assess the Effect of Change of Bile Acid on the PD and Safety of Metformin and Microbiome ProfilesCompletedNCT04335526Phase 1
- Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt HyperthyroidismStatus unknownNCT03303053Phase 3
- A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384CompletedNCT02963077Phase 1
- Effect of Lipid Modifying Drugs on HDL Function in Patients With HyperlipidemiaCompletedNCT02942602Not applicable
- PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEsCompletedNCT02249897Phase 4
- Double-blind, Randomised Study of A3384 in BAM/BADCompletedNCT02078856Phase 2
- A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese VolunteersCompletedNCT02046629Phase 1
- Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple SclerosisCompletedNCT01863888Phase 3
- Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal ImpairmentCompletedNCT01239459Phase 1
- Low Doses of Cholestyramine in the Treatment of HyperthyroidismCompletedNCT00677469Not applicable
- NHLBI Type II Coronary Intervention StudyCompletedNCT00000594Phase 3
- Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)CompletedNCT00000488Phase 3